All Articles tagged body mass index

• Infectious Diseases
  February 14, 2022 EDT
  Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States
  Bruno EmondCarmine RossiRachel RogersPatrick LefebvreMarie-Hélène LafeuillePrina Donga

  To evaluate weight-related outcomes among patients with HIV-1 in the United States initiating antiretroviral therapy containing different nucleoside reverse transcriptase inhibitors and doses.

  Abstract
• Infectious Diseases
  June 14, 2021 EDT
  Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study
  Bruno EmondCarmine RossiAurélie Côté-SergentKeith DunnPatrick LefebvreMarie-Hélène LafeuillePrina Donga

  To describe demographic and clinical characteristics of insured patients with HIV-1 in the United States initiating darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/FTC/TAF, assess the differences in weight and BMI between cohorts.

  Abstract